Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia (Q36709001)
Jump to navigation
Jump to search
scientific article published on 28 May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia |
scientific article published on 28 May 2015 |
Statements
1 reference
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia (English)
1 reference
Mark R Litzow
1 reference
Joshua F Zeidner
1 reference
Matthew C Foster
1 reference
Amanda L Blackford
1 reference
Lawrence E Morris
1 reference
Stephen A Strickland
1 reference
Jeffrey E Lancet
1 reference
Prithviraj Bose
1 reference
M Yair Levy
1 reference
Raoul Tibes
1 reference
Ivana Gojo
1 reference
Christopher D Gocke
1 reference
Gary L Rosner
1 reference
Richard F Little
1 reference
John J Wright
1 reference
L Austin Doyle
1 reference
B Douglas Smith
1 reference
Judith E Karp
1 reference
28 May 2015
1 reference
1 reference
1172-1179
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference